Literature DB >> 17562221

Differences in the association between structural factors and diabetes self-monitoring support.

Michiel J Storimans1, Olaf H Klungel, Herre Talsma, Cornelis J de Blaey.   

Abstract

OBJECTIVE: To determine if the association between the level of community pharmacy diabetes services and six of its reported determinants is influenced by the definition of these services.
METHOD: Cross-sectional survey among 97% of all Dutch community pharmacies (1,642) registered in 2004. Seven definitions of self-monitoring support (support to patients performing self-monitoring of blood glucose) were constructed: one based on the Dutch pharmacy practice guideline (containing five activities related to patient counselling, calibration and dispensing), one based on patient counselling activities only and five definitions based on each separate activity. Multivariable models of self-monitoring support according to the different definitions were compared. MAIN OUTCOME MEASURE: Associations between determinants and the different definitions of self-monitoring support, expressed as odds ratio (OR) and 95% confidence intervals (95% CI). All definitions were compared to the practice guideline definition.
RESULTS: The ORs of 14 of the 48 possible comparisons of different definitions were significantly different from one. The standardized difference ranged from 1.42 (95% CI: 1.01-1.90) to 3.05 (95% CI: 1.51-4.61). Three out of six predictive models retained different determinants compared to the multivariable model of self-monitoring support based on the guideline.
CONCLUSION: The association between self-monitoring support and its determinants depend on the definition of self-monitoring support. This underlines the importance for pharmacy practice research to unambiguously describe the characteristics and the setting of an intervention. Only with a complete description of the intervention, the likelihood for success of implementation in another setting can be determined.

Entities:  

Mesh:

Year:  2007        PMID: 17562221     DOI: 10.1007/s11096-007-9128-9

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  9 in total

1.  Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment.

Authors:  Carmel M Hughes; Siobhan McCann
Journal:  Br J Gen Pract       Date:  2003-08       Impact factor: 5.386

2.  The Asheville Project: short-term outcomes of a community pharmacy diabetes care program.

Authors:  Carole W Cranor; Dale B Christensen
Journal:  J Am Pharm Assoc (Wash)       Date:  2003 Mar-Apr

3.  The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program.

Authors:  Carole W Cranor; Barry A Bunting; Dale B Christensen
Journal:  J Am Pharm Assoc (Wash)       Date:  2003 Mar-Apr

4.  Pharmacists' attitudes toward diabetes and their involvement in diabetes education.

Authors:  W S Younis; S Campbell; M K Slack
Journal:  Ann Pharmacother       Date:  2001 Jul-Aug       Impact factor: 3.154

5.  Perceived barriers to the implementation of diabetes guidelines in hospitals in The Netherlands.

Authors:  R F Dijkstra; J C Braspenning; E Uiters; E van Ballegooie; R T Grol
Journal:  Neth J Med       Date:  2000-03       Impact factor: 1.422

6.  Pharmacist-led, primary care-based disease management improves hemoglobin A1c in high-risk patients with diabetes.

Authors:  Russell Rothman; Robb Malone; Betsy Bryant; Cheryl Horlen; Michael Pignone
Journal:  Am J Med Qual       Date:  2003 Mar-Apr       Impact factor: 1.852

7.  Evaluation of a pharmaceutical care model on diabetes management.

Authors:  L A Jaber; H Halapy; M Fernet; S Tummalapalli; H Diwakaran
Journal:  Ann Pharmacother       Date:  1996-03       Impact factor: 3.154

8.  Management of patients with type 2 diabetes by pharmacists in primary care clinics.

Authors:  E A Coast-Senior; B A Kroner; C L Kelley; L E Trilli
Journal:  Ann Pharmacother       Date:  1998-06       Impact factor: 3.154

9.  The role of patient, physician and systemic factors in the management of type 2 diabetes mellitus.

Authors:  Judith Belle Brown; Stewart B Harris; Susan Webster-Bogaert; Stephen Wetmore; Catherine Faulds; Moira Stewart
Journal:  Fam Pract       Date:  2002-08       Impact factor: 2.267

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.